SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4

NCT02941328 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Spinal Muscular Atrophy
SMA
Kugelberg-Welander Disease

Interventions

DRUG: Pyridostigmine
DRUG: Placebo

Sponsor

UMC Utrecht